PL1661579T3 - Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi - Google Patents

Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi

Info

Publication number
PL1661579T3
PL1661579T3 PL04775224T PL04775224T PL1661579T3 PL 1661579 T3 PL1661579 T3 PL 1661579T3 PL 04775224 T PL04775224 T PL 04775224T PL 04775224 T PL04775224 T PL 04775224T PL 1661579 T3 PL1661579 T3 PL 1661579T3
Authority
PL
Poland
Prior art keywords
qualitative
changes
bacterial infection
quantitative composition
infection associated
Prior art date
Application number
PL04775224T
Other languages
English (en)
Inventor
Dmitry Dmitrievich Genkin
Victor Veniaminovich Tets
Georgy Victorovich Tets
Original Assignee
Cls Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/RU2003/000304 external-priority patent/WO2005007187A1/ru
Application filed by Cls Therapeutics Ltd filed Critical Cls Therapeutics Ltd
Publication of PL1661579T3 publication Critical patent/PL1661579T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04775224T 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi PL1661579T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/RU2003/000304 WO2005007187A1 (en) 2003-07-14 2003-07-14 Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment
RU2004108057/14A RU2269358C2 (ru) 2003-07-14 2004-03-12 Способ лечения генерализованных инфекций, вызываемых бактериями, или заболеваний, вызываемых грибами и простейшими, или атеросклероза, или сахарного диабета, или заболеваний, связанных с реакцией гиперчувствительности замедленного типа, или заболеваний, обусловленных мутациями генов соматических клеток
PCT/RU2004/000260 WO2005004789A2 (en) 2003-07-14 2004-07-01 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna
EP04775224A EP1661579B1 (en) 2003-07-14 2004-07-01 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna

Publications (1)

Publication Number Publication Date
PL1661579T3 true PL1661579T3 (pl) 2012-11-30

Family

ID=34067506

Family Applications (4)

Application Number Title Priority Date Filing Date
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL04775224T PL1661579T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Country Status (6)

Country Link
US (1) US20070104702A1 (pl)
EP (4) EP2497487B1 (pl)
ES (4) ES2434111T3 (pl)
PL (4) PL2497488T3 (pl)
RU (1) RU2269358C2 (pl)
WO (1) WO2005004789A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
EP1880733A4 (en) * 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich Method for increasing longevity of a human being and animals
KR20090087095A (ko) 2006-11-28 2009-08-14 드미트리 드미트리에비치 겐킨 조직의 세포외공간에서 증가된 데옥시리보핵산 함량과 관련된 인간 질병을 치료하는 방법 및 이 방법을 수행하기 위한 약학 제제
RU2481100C2 (ru) * 2009-10-16 2013-05-10 Лайфкеа Инновейшнз Пвт. Лтд. Новая лекарственная форма для лечения грибковой инфекции
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
RU2726131C2 (ru) * 2015-05-22 2020-07-09 Дмитрий Дмитриевич Генкин Внеклеточная днк в качестве терапевтической мишени при нейродегенерации
US11905522B2 (en) 2018-01-16 2024-02-20 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024530A1 (de) * 1990-08-02 1992-02-06 Klinger & Co Dr Verfahren zur bekaempfung von viren
FR2666096B1 (fr) * 1990-08-21 1993-12-31 Sfri Sa Nouveau procede de dosage d'acide desoxyribonucleique present en position extracellulaire dans un milieu.
US5484589A (en) * 1992-04-20 1996-01-16 Rufeld, Inc. Anti-viral methods using RNAse and DNAse
NZ331063A (en) * 1996-02-05 2000-03-27 Inc Genentech Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition
US6391607B1 (en) * 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
EP1666055A4 (en) * 2003-07-14 2010-02-10 Viktor Veniaminovich Tets METHOD OF TREATMENT OF ONCOLOGICAL, INFECTIOUS, AND SOMATIC DISEASES, METHODS OF MONITORING THE EFFICACY OF TREATMENT, AGENTS AND PHARMACEUTICAL COMPOSITIONS THEREOF

Also Published As

Publication number Publication date
EP1661579B1 (en) 2012-06-06
ES2434112T3 (es) 2013-12-13
RU2269358C2 (ru) 2006-02-10
RU2004108057A (ru) 2005-09-27
EP1661579A4 (en) 2009-11-25
EP2497487A1 (en) 2012-09-12
EP2497488B1 (en) 2013-08-07
ES2434111T3 (es) 2013-12-13
ES2433918T3 (es) 2013-12-13
ES2388605T3 (es) 2012-10-16
EP2497488A1 (en) 2012-09-12
PL2497486T3 (pl) 2014-01-31
WO2005004789A2 (en) 2005-01-20
EP2497486A1 (en) 2012-09-12
EP2497487B1 (en) 2013-08-07
US20070104702A1 (en) 2007-05-10
PL2497488T3 (pl) 2014-01-31
WO2005004789A3 (en) 2005-03-24
EP1661579A2 (en) 2006-05-31
PL2497487T3 (pl) 2014-01-31
EP2497486B1 (en) 2013-08-07

Similar Documents

Publication Publication Date Title
DE60303572D1 (de) Katheter und Verfahren zur Darstellung von Purkinje-Fasern
AU2002233643A1 (en) Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases
AU2003233451A8 (en) Targets, methods, and reagents for diagnosis and treatment of schizophrenia
GB2412913A8 (en) Compositions and methods for preserving rna in biological samples
AU2003300053A1 (en) Multi-chamber treatment apparatus and method
DE60133982D1 (de) Biosensor und verfahren zum analysieren von blutkomponenten
EP1531828A4 (en) METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES
EP1613334A4 (en) ALCOHOL-FREE TRANSDERMAL INSULIN COMPOSITION AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP1659169A4 (en) DEVICE FOR TREATING CULTURES AND AUTOCULTIVATION DEVICE
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
EP1468005A4 (en) METHODS OF USING SACCHARIDE CONJUGATES AND ACETAMIDINE OR GUANIDINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
IL172652A0 (en) Method for the detection of gene transcripts in blood and uses thereof
EP1661579A4 (en) METHOD OF TREATING DISEASES ACCOMPANYING ALTERATIONS IN THE QUALITATIVE OR QUANTITATIVE COMPOSITION OF EXTRACELLULAR BLOOD DNA
WO2005030131A3 (en) Bis-quinazoline compounds for the treatment of bacterial infections
AU2003244132A8 (en) Method of examining allergic disaese and drug for treating the same
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2002367706A1 (en) Method and apparatus for analyizing biological tissue specimens
DE602004004708D1 (de) Vorrichtung und Verfahren zur Bestimmung von Bakterien
AU2003237870A8 (en) Method and composition for inhibing or slowing blood coagulation
AU2003228787A8 (en) Composition and method for reducing post-prandial blood glucose
FI20010352A0 (fi) Menetelmä bakteerien ja bakteeriryhmien osoittamiseksi
AU2003903389A0 (en) Method of biological control of skin infections and defects
AU2003907034A0 (en) Method of biological control of skin infections and defects
AU2003258177A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
HK1094952A (en) System and method for increasing concentration of sterilant in region